Astrana Health (NASDAQ:ASTH) Sets New 12-Month Low - Here's What Happened

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) hit a new 52-week low during mid-day trading on Friday . The company traded as low as $34.04 and last traded at $34.11, with a volume of 324004 shares trading hands. The stock had previously closed at $35.09.

Wall Street Analysts Forecast Growth

ASTH has been the topic of a number of recent research reports. Robert W. Baird upped their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. Macquarie raised Astrana Health to a "hold" rating in a research report on Monday. KeyCorp assumed coverage on Astrana Health in a research note on Friday, October 11th. They issued a "sector weight" rating on the stock. TD Cowen began coverage on Astrana Health in a research note on Monday, October 14th. They set a "buy" rating and a $66.00 price objective for the company. Finally, BTIG Research increased their target price on Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday, October 3rd. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $65.17.

Astrana Health Trading Down 4.0 %

The firm has a market capitalization of $1.90 billion, a PE ratio of 25.92, a P/E/G ratio of 1.80 and a beta of 1.13. The firm has a 50 day simple moving average of $47.22 and a 200 day simple moving average of $47.84. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $478.71 million for the quarter, compared to analysts' expectations of $462.01 million. During the same period last year, the firm posted $0.47 earnings per share. Equities analysts expect that Astrana Health, Inc. will post 1.16 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Central Pacific Bank Trust Division bought a new position in shares of Astrana Health during the 3rd quarter valued at $160,000. SG Americas Securities LLC purchased a new stake in Astrana Health during the third quarter valued at $680,000. Granite Bay Wealth Management LLC bought a new position in Astrana Health in the third quarter valued at about $290,000. Handelsbanken Fonder AB purchased a new position in Astrana Health in the third quarter worth about $492,000. Finally, GAMMA Investing LLC bought a new stake in shares of Astrana Health during the 3rd quarter valued at about $34,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.